[Progess on research of herpes simplex virus type 1 mutants for cancer therapy].

  • Yahong Long, Yanxia Mi, Yunchun Li
  • Published 2008 in Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi

Abstract

For a long time past viruses have been recognized as being tumoricidal. At present, researchers are still pursuing studies and constructing more suitable oncolytic viruses for treating different malignant tumors. Herpes simplex virus type 1 (HSV-1) has been known as the most potential oncolytic virus among all the viruses. In this overview, we summarize the current situation of oncolytic viruses, the biology of HSV-1, its construction and application of its recombinant, and we debate on the feasibility and prospect of HSV-1 mutants labeled with radionuclides for cancer therapy.

Topics

    0 Figures and Tables

      Download Full PDF Version (Non-Commercial Use)